These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24698870)

  • 1. Re: proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Abdallah J; Hassan T; Kyprianou A
    Am J Gastroenterol; 2014 Apr; 109(4):601-2. PubMed ID: 24698870
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: PPIs and recurrent C. difficile infection: no association?
    Leontiadis GI
    Am J Gastroenterol; 2013 Nov; 108(11):1802-3. PubMed ID: 24192949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggression of C-difficile infections in PPI consumers.
    Daniell HW
    Am J Gastroenterol; 2014 Jun; 109(6):922. PubMed ID: 24896760
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Daniell.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2014 Jun; 109(6):922-3. PubMed ID: 24896761
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to Abdallah et al.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2014 Apr; 109(4):602-3. PubMed ID: 24698871
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastric acid suppression and Clostridium difficile infection: is there a causal connection?
    Khanna S; Pardi DS
    Clin Gastroenterol Hepatol; 2012 May; 10(5):564; author reply 564. PubMed ID: 22289872
    [No Abstract]   [Full Text] [Related]  

  • 7. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection: managing the risks.
    DeDea L
    JAAPA; 2012 May; 25(5):16. PubMed ID: 22712142
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium difficile.
    Baierlein SA; Wistop A
    N Engl J Med; 2009 Feb; 360(6):636-7; author reply 637-8. PubMed ID: 19202581
    [No Abstract]   [Full Text] [Related]  

  • 10. Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.
    Roughead EE; Chan EW; Choi NK; Griffiths J; Jin XM; Lee J; Kimura M; Kimura T; Kubota K; Lai EC; Man KK; Nguyen TA; Ooba N; Park BJ; Sato T; Shin JY; Wang T; Wong IC; Yang YK; Pratt NL
    Expert Opin Drug Saf; 2016 Dec; 15(12):1589-1595. PubMed ID: 27645304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
    Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
    World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection in solid-organ transplant recipients.
    Cross TJ; Berry PA; Burroughs AK
    N Engl J Med; 2008 Mar; 358(12):1302. PubMed ID: 18354113
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton pump inhibitors are an independent risk factor for an increased length of hospital stay in patients with Clostridium difficile infection.
    Nachnani JS; Bulchandani D; Allen MJ
    Indian J Gastroenterol; 2008; 27(4):171-2. PubMed ID: 18974472
    [No Abstract]   [Full Text] [Related]  

  • 14. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
    Leonard AD; Ho KM; Flexman J
    Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discussion.
    Surgery; 2014 Oct; 156(4):978. PubMed ID: 25151554
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of quality appraisal in meta-analysis.
    Mahady SE; Webster AC
    Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1057; author reply 1057-8. PubMed ID: 22503999
    [No Abstract]   [Full Text] [Related]  

  • 19. Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection.
    Min JH; Kim YS
    Gut Liver; 2016 Jul; 10(4):493-4. PubMed ID: 27377737
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Proton Pump Inhibitors and Risk of Nosocomial Clostridium Difficile Infection in Hospitalized Elderly Adults.
    Depoorter L; Verhaegen J; Joosten E
    J Am Geriatr Soc; 2016 Mar; 64(3):667-9. PubMed ID: 27000353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.